Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations

Gen Pharmacol. 1996 Oct;27(7):1255-9. doi: 10.1016/0306-3623(95)02145-0.

Abstract

1. The calcium-channel blocking activity of lacidipine has been studied compared with that of nifedipine and verapamil on the isolated rabbit heart and aorta. 2. All the compounds induced a dose-dependent negative inotropic effect (10(-8)-10(-5) M); although lacidipine showed less, but longer lasting, activity. 3. Lacidipine showed a weak negative chronotropic effect and nifedipine was ineffective. Only verapamil strongly decreased the heart rate. 4. The three calcium antagonists abolished vasopressin-induced coronary spasm and inhibited partially metoxamine-induced coronary spasm. Only lacidipine reduced basal coronary pressure. 5. In the aortic strips, all the compounds antagonized KCl-induced contractions, and they exerted a partial effect on noradrenaline- and angiotensin II-induced contractions.

MeSH terms

  • Animals
  • Aorta, Thoracic / drug effects
  • Calcium Channel Blockers / pharmacology*
  • Coronary Circulation / drug effects
  • Dihydropyridines / pharmacology*
  • Female
  • Heart / drug effects
  • Heart Rate / drug effects
  • In Vitro Techniques
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Myocardial Contraction / drug effects
  • Nifedipine / pharmacology
  • Rabbits
  • Ventricular Pressure / drug effects
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Dihydropyridines
  • lacidipine
  • Verapamil
  • Nifedipine